Malignant Nasopharyngeal Neoplasm — Trials

Malignant Nasopharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 261
Recruiting: 139
Ph III recruiting: 56
Growth YoY: +5.2%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 24.1%
Trials / 1,000 deaths: 376.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 451–500 of 771 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04834206	Nedaplatin in Treatment for Nasopharyngeal Carcinoma	completed	Phase 2	32	Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER	1	May 10, 2022	clinicaltrials
NCT05350891	Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC	unknown	Phase 2	77	Eye & ENT Hospital of Fudan UniversityOTHER	1	May 10, 2022	clinicaltrials